BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25058344)

  • 1. Metal complexes with 2-acetylpyridine-N(4)-orthochlorophenylthiosemicarbazone: cytotoxicity and effect on the enzymatic activity of thioredoxin reductase and glutathione reductase.
    Parrilha GL; Ferraz KS; Lessa JA; de Oliveira KN; Rodrigues BL; Ramos JP; Souza-Fagundes EM; Ott I; Beraldo H
    Eur J Med Chem; 2014 Sep; 84():537-44. PubMed ID: 25058344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal complexes of 3-(4-bromophenyl)-1-pyridin-2-ylprop-2-en-1-one thiosemicarbazone: cytotoxic activity and investigation on the mode of action of the gold(III) complex.
    Sâmia LB; Parrilha GL; Da Silva JG; Ramos JP; Souza-Fagundes EM; Castelli S; Vutey V; Desideri A; Beraldo H
    Biometals; 2016 Jun; 29(3):515-26. PubMed ID: 27091443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold(I) complexes with thiosemicarbazones: cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity.
    Lessa JA; Guerra JC; de Miranda LF; Romeiro CF; Da Silva JG; Mendes IC; Speziali NL; Souza-Fagundes EM; Beraldo H
    J Inorg Biochem; 2011 Dec; 105(12):1729-39. PubMed ID: 22005449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors.
    Cheng Y; Qi Y
    Anticancer Agents Med Chem; 2017; 17(8):1046-1069. PubMed ID: 28270080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectroscopic and electrochemical characterization of gold(I) and gold(III) complexes with glyoxaldehyde bis(thiosemicarbazones): cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity.
    Lessa JA; Ferraz KS; Guerra JC; de Miranda LF; Romeiro CF; Souza-Fagundes EM; Barbeira PJ; Beraldo H
    Biometals; 2012 Jun; 25(3):587-98. PubMed ID: 22526562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.
    Witte AB; Anestål K; Jerremalm E; Ehrsson H; Arnér ES
    Free Radic Biol Med; 2005 Sep; 39(5):696-703. PubMed ID: 16085187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer profile of a series of gold(III) (2-phenyl)pyridine complexes.
    Rubbiani R; Zehnder TN; Mari C; Blacque O; Venkatesan K; Gasser G
    ChemMedChem; 2014 Dec; 9(12):2781-90. PubMed ID: 25377650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
    Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
    Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin.
    Prast-Nielsen S; Cebula M; Pader I; Arnér ES
    Free Radic Biol Med; 2010 Dec; 49(11):1765-78. PubMed ID: 20851179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
    Ng HL; Chen S; Chew EH; Chui WK
    Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
    Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
    J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cobaltoceniumethynyl gold(I) as an unusual heterodinuclear bioorganometallic fragment to study the biological properties of alkynyl gold complexes.
    Vanicek S; Kopacka H; Wurst K; Vergeiner S; Kankowski S; Schur J; Bildstein B; Ott I
    Dalton Trans; 2016 Jan; 45(4):1345-8. PubMed ID: 26732365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
    Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
    Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold(I) thiotetrazolates as thioredoxin reductase inhibitors and antiproliferative agents.
    Serebryanskaya TV; Lyakhov AS; Ivashkevich LS; Schur J; Frias C; Prokop A; Ott I
    Dalton Trans; 2015 Jan; 44(3):1161-9. PubMed ID: 25413270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold(I) N-heterocyclic carbene complexes with naphthalimide ligands as combined thioredoxin reductase inhibitors and DNA intercalators.
    Meyer A; Oehninger L; Geldmacher Y; Alborzinia H; Wölfl S; Sheldrick WS; Ott I
    ChemMedChem; 2014 Aug; 9(8):1794-800. PubMed ID: 24803348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl
    Truong D; Sullivan MP; Tong KKH; Steel TR; Prause A; Lovett JH; Andersen JW; Jamieson SMF; Harris HH; Ott I; Weekley CM; Hummitzsch K; Söhnel T; Hanif M; Metzler-Nolte N; Goldstone DC; Hartinger CG
    Inorg Chem; 2020 Mar; 59(5):3281-3289. PubMed ID: 32073260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions.
    Rigobello MP; Messori L; Marcon G; Agostina Cinellu M; Bragadin M; Folda A; Scutari G; Bindoli A
    J Inorg Biochem; 2004 Oct; 98(10):1634-41. PubMed ID: 15458826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N(4)-tolyl-2-acetylpyridine thiosemicarbazones and their platinum(II,IV) and gold(III) complexes: cytotoxicity against human glioma cells and studies on the mode of action.
    Ferraz KS; Da Silva JG; Costa FM; Mendes BM; Rodrigues BL; dos Santos RG; Beraldo H
    Biometals; 2013 Oct; 26(5):677-91. PubMed ID: 23749148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold(III) bis(thiosemicarbazonate) compounds in breast cancer cells: Cytotoxicity and thioredoxin reductase targeting.
    Rodríguez-Fanjul V; López-Torres E; Mendiola MA; Pizarro AM
    Eur J Med Chem; 2018 Mar; 148():372-383. PubMed ID: 29471123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong inhibition of thioredoxin reductase by highly cytotoxic gold(I) complexes. DNA binding studies.
    Ortego L; Cardoso F; Martins S; Fillat MF; Laguna A; Meireles M; Villacampa MD; Gimeno MC
    J Inorg Biochem; 2014 Jan; 130():32-7. PubMed ID: 24157605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.